Frances Seymour

9PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Predictive and prognostic markersAutoimmunityInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Mar 08, 2026
Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival.

Maeve A O'Reilly, William Wilson, Bernard Maybury

|Apr 10, 2024
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.

A Kuhnl, C Roddie, A A Kirkwood

|Oct 17, 2023
Improved outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK over time.

S Boyle, C Roddie, M O'Reilly

|Aug 21, 2023
A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction.

Thea Chandler, Christopher Parrish, Marina Karakantza

|Mar 16, 2023
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.

Jonathan Carmichael, Frances Seymour, Graham McIlroy

Pageof 2

Frequent Collaborators

4 joint publications

Robin Sanderson

3 joint publications

Claire Roddie

3 joint publications

Andrea Kuhnl

2 joint publications

Jonathan Carmichael